RxDoctor Payments Data

Ashley Tamasovich, PA

Physician Assistant · Zanesville, OHNPI 1104078914

Payments from drug & device makers

$5,229in general payments, 2019–2025

Across 259 payments — averaging $20.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • AbbVie$1K
  • E.r. Squibb & Sons, L.L.C.$568
  • Regeneron Healthcare Solutions, Inc.$559
  • Novartis$477
  • Lilly USA, LLC$207
  • plus $803 from 17 others

What the payments were for

  • Food & beverage$4,56387%
  • Education$66613%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,229 in reported general payments places this provider in the 90th percentile of 4,098 physician assistant providers in Ohio.

See all physician assistant providers in Ohio

Medicare billing

Part B allowed, 2024
$155,510
Medicare patients
706
Services billed
3,272

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa22$448,670
Humira(Cf) PenAdalimumab26$237,791
Cosentyx Sensoready (2 Pens)Secukinumab29$204,160
Humira(Cf)Adalimumab16$108,985
Cosentyx Unoready PenSecukinumab11$79,446
Taltz AutoinjectorIxekizumab12$75,799
OtezlaApremilast14$65,602
Dupixent PenDupilumab13$47,591
Clobetasol Propionate47$2,326
Ketoconazole86$2,043
Metronidazole21$1,683
Fluocinonide41$1,622
Triamcinolone Acetonide117$1,308
Fluorouracil16$1,283
Doxycycline Hyclate68$883

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieHumira(Cf)$1,174$108,98516 claims
AmgenOtezla$134$65,60214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,098 physician assistant providers in Ohio.

Other physician assistant in Zanesville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →